Inventor · disambiguated record
Zenjiro Sampei
Also filed as: SAMPEI ZENJIRO
13 granted patents·30 pending applications·349 citations·filing 2010–2025
92Inventor score
Top patents by PatentIndex Score
43 records- 0197US9765135B2Anti-C5 antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Granted Sep 19, 2017·51 cites·66 claims
- 0296US9334331B2Bispecific antibodiesIGAWA TOMOYUKI·Filed 2011·Granted May 10, 2016·221 cites·33 claims
- 0395US10450381B2Methods of treatment that include the administration of bispecific antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Granted Oct 22, 2019·28 cites·84 claims
- 0494US11597760B2Method of detecting the presence of complement C5CHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Mar 7, 2023·6 cites·10 claims
- 0594US10385122B2Nucleic acids encoding anti-C5 antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Aug 20, 2019·14 cites·58 claims
- 0694US10023630B2Methods of neutralizing C5 with anti-C5 antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Granted Jul 17, 2018·14 cites·70 claims
- 0793US10604561B2Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Granted Mar 31, 2020·11 cites·15 claims
- 0892US12187786B2Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Jan 7, 2025·1 cites·1 claims
- 0992US2025382387A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 1089US2025382327A1Polypeptide modification method for purifying polypeptide multimersCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 1189US2024376228A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1288US2024059795A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1387US2024391952A1Polypeptide modification method for purifying polypeptide multimersCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1486US2024083939A1Polypeptide modification method for purifying polypeptide multimersCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1584US10844113B2Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Nov 24, 2020·2 cites·11 claims
- 1684US2023212315A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1783US2023227498A1Polypeptide modification method for purifying polypeptide multimersCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1882US2024052021A1Anti-c5 antibodies and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1981US2022267470A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2080US2022389054A1Polypeptide modification method for purifying polypeptide multimersCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2178US11608374B2Anti-sclerostin antibodies and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Mar 21, 2023·1 cites·8 claims
- 2278US2022135618A1Polypeptide modification method for purifying polypeptide multimersCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2377US2025154285A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 2475US2021292360A1Polypeptide modification method for purifying polypeptide multimersCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2573US12209121B2Anti-sclerostin antibodies and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Jan 28, 2025·0 cites·8 claims
- 2672US11780908B2Anti-dengue virus antibodies, polypeptides containing variant FC regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Granted Oct 10, 2023·0 cites·6 claims
- 2772US2021040147A1Polypeptide modification method for purifying polypeptide multimersCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 2871US2024190948A1Anti-dengue virus antibodies having cross-reactivity to zika virus and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 2970US2019315884A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 3070US2019352334A1Polypeptide modification method for purifying polypeptide multimersCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 3170US2020207805A1Polypeptide modification method for purifying polypeptide multimersCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 3268US2019062368A1Polypeptide modification method for purifying polypeptide multimersCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 3368US2023250162A1Pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related diseaseCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 3465US2018162902A1Polypeptide modification method for purifying polypeptide multimersCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 3564US2017275332A1Polypeptide modification method for purifying polypeptide multimersCHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
- 3664US2014370018A1Multi-specific antigen-binding molecules and uses thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 3764US2014037632A1Multi-specific antigen-binding molecules and uses thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 3863US2017022293A1Nucleic acid encoding bispecific antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 3960US11891432B2Anti-dengue virus antibodies having cross-reactivity to Zika virus and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Feb 6, 2024·0 cites·2 claims
- 4058US2013018174A1Polypeptide modification method for purifying polypeptide multimersCHUGAI PHARMACEUTICAL CO LTD·Filed 2010·Application pending·0 cites
- 4156US2020407432A1Pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related diseaseCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 4246US2019367599A1Pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related diseaseCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 4344US2022253669A1Information processing system, information processing method, program, and method for producing antigen-binding molecule or proteinCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zenjiro Sampei files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →